Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies – FierceBiotech
FierceBiotech |
Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies
FierceBiotech Novo Nordisk has talked up the progress of its Type 1 diabetes stem cell therapy program. With the diabetes project clearing milestones and moving to within a few years of the clinic, Novo is stepping up its interest in stem cell therapies more broadly. Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborationsEndpoints News Novo expands type 1 diabetes R&Dpharmaphorum |
MarketWatch |
Can gene therapy make you super-strong like Jessica Jones? Yes — but it’s complicated
MarketWatch Gene therapy, that very procedure, is already being used to treat complex diseases, with hopes of using it far more widely. Human capabilities could likely be enhanced through gene therapy, possibly attaining even some of the abilities pictured on the … |
PR Newswire (press release) |
USRM Chief Scientist Talks Stem Cell Journey, Autologous Stem Cells with ‘Something Significant’ Happy Living Podcast
PR Newswire (press release) SUNRISE, Fla., May 17, 2018 /PRNewswire/ — U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr … |
|
Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for …
Nasdaq Previously reported data from a Phase 1b clinical trial demonstrated that Inovio’s cancer immunotherapy (INO-5150) slowed PSA rise in patients with biochemically recurrent prostate cancer. Additional analyses show clinically meaningful PSA … |